During clinical trials, adults using semaglutide injections lost an average of almost 15% of their initial body weight, which is comparable to the pill form
Disclosures Jos Luis Grriz has served as consultant to Boehringer Ingelheim, Mundipharma, AstraZeneca, and Novo Nordisk and has received speaker honoraria from Boehringer Ingelheim, Mundipharma, AstraZeneca, Novo Nordisk, Novartis, and Eli Lilly and Company
Self-prescribing supplements without medical guidance may delay appropriate investigation of potentially significant digestive problems
Managing Type 2 diabetes often involves boosting insulin secretion and enhancing the bodys sensitivity to insulin, allowing glucose to be absorbed more easily by the liver and muscles